Search

everythinglearnresearchcommunity

for

Search:↓

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Cetuximab can cause excessive eyelash growth.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Genes and hormones cause hair loss, with four genes contributing equally.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Anorexia nervosa can cause skin problems, which may help with early diagnosis and usually improve with treatment.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.